World Of Taxonomy
50242-583Level 3

Xofluza (BALOXAVIR MARBOXIL)

**Product type:** Human Prescription Drug

**Active ingredient:** BALOXAVIR MARBOXIL

**Strength:** 40 mg/20mL

**Dosage form:** Granule, For Solution

**Route:** Oral

**Labeler:** Genentech, Inc.

**Marketing category:** NDA (NDA214410)

**Pharmacologic class:** Chelating Activity [MoA], Polymerase Acidic Endonuclease Inhibitor [EPC], Polymerase Acidic Endonuclease Inhibitors [MoA]

GET/api/v1/systems/ndc_fda/nodes/50242-583
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.